Page 29 - Amgen News Today

UTRECHT, Netherlands, May 30, 2024 /PRNewswire/ -- FutureBridge, a leading techno-commercial consulting and advisory company focussing on R&D, innovation, strategy, scientific evidence, markets

UTRECHT, Netherlands, May 30, 2024 /PRNewswire/ -- FutureBridge , a leading techno-commercial consulting and advisory company focussing on R&D,

Amgen Inc. (NASDAQ:AMGN – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-one brokerages that are covering the stock, Marketbeat Ratings reports. Ten research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year price objective among brokers […]

The Tina-quant Lp(a) RxDx assay identifies adults with elevated Lp(a) levels who might benefit from innovative lipid-lowering therapies currently in development.

Lcnb Corp boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,314 shares of the medical research company’s stock after purchasing an additional 36 shares during the period. Lcnb Corp’s holdings in […]

Journey Advisory Group LLC increased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,743 shares of the medical research company’s stock after buying an additional 327 shares during the period. Journey […]

As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly , increasing supplies, possible wider usage and a growing number of would-be rivals are leading some experts to raise annual global sales forecasts for the treatments to about $150 billion by the early 2030s.

Legacy Advisors LLC lowered its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 21.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,155 shares of the medical research company’s stock after selling 3,021 shares during the period. Legacy Advisors LLC’s holdings in Amgen […]

Roche announces that the Tina-quant lipoprotein Lp(a) RxDx assay receives Breakthrough Device Designation from the FDA

Latest health news includes Louisiana's reclassification of abortion pills as controlled substances, the effectiveness of bird flu vaccines in laying hens, and rising forecasts for weight-loss drug sales. Other updates cover M&A deals, CEO retirements, Neuralink's brain implant study, and WHO's push for pandemic response rules.